Heparin: an overview
Maguire, F.W.
Delaware Medical Journal 51(8): 439-449
1979
ISSN/ISBN: 0011-7781 PMID: 385374 Document Number: 150979
Document emailed within 1 workday
Related Documents
Mousa, S.A.; Fareed, J. 2001: Overview: from heparin to low molecular weight heparin: beyond anticoagulation Current Opinion in Investigational Drugs 2(8): 1077-1080Lapka, D.M.; Wild, L.D.; Barbour, L.A. 1994: Heparin-induced thrombocytopenia and thrombosis: a case study and clinical overview Oncology Nursing Forum 21(5): 871-876
Bernardi, E.; Piccioli, A.; Oliboni, G.; Zuin, R.; Girolami, A.; Prandoni, P. 2000: Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview Thrombosis and Haemostasis 84(1): 22-26
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Kruse-Blinkenberg, H.O.; Gormsen, J. 1976: Heparin concentration in blood pre- and postoperatively in surgical patients with low dosage heparin prophylaxis Ugeskrift for Laeger 138(12): 745-747
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Lagasse, J.P.; Bahallah, M.L.; Salem, N.; Debillon, G.; Labarrière, D.; Serve, M.P.; Advenier, V.; Causse, X.; Legoux, J.L. 1997: Acute thrombosis of the portal system. Treatment with alteplase and heparin or with heparin alone in 10 patients Gastroenterologie Clinique et Biologique 21(12): 919-923
Zimmermann, R.E.; Schwering, H.; Wittrin, G.; Hollenders, T. 1981: Control of low-dose heparin therapy using photometry to detect biologically active heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 52(5): 316-319
Sampol, J.; Rossi, J.M.; Lejay, G. 1984: Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex Annales de Biologie Clinique 42(1): 21-23
Bannon, P.G.; Kim, M.J.; Dean, R.T.; Dawes, J. 1995: Augmentation of vascular endothelial barrier function by heparin and low molecular weight heparin Thrombosis and Haemostasis 73(4): 706-712
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Melissari, E.; Thye, C.; Scully, M.F.; Kakkar, V.V. 1989: Influence of whole blood on standard curve for heparin measurement--possible heparin binding by red cells Thrombosis and Haemostasis 61(2): 262-265
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Izban, K.F.; Lietz, H.W.; Hoppensteadt, D.A.; Jeske, W.P.; Fareed, J.; Bakhos, M.; Walenga, J.M. 1999: Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia Seminars in Thrombosis and Hemostasis 25(Suppl 1): 51-56
Kudriashov, B.A.; Liapina, L.A.; Molchanova, L.V.; Rustamova, B.A. 1970: Nature of lytic effect of fibrinogen-heparin and thyroxine-heparin complexes on fibrin Voprosy Meditsinskoi Khimii 16(2): 161-168
Schmid, M.G.; Sadjak, A.; Likar, R.; Wintersteiger, R. 1998: Biocompatibility of heparin and low-molecular mass heparin in a new implantable medication pump Arzneimittel-Forschung 48(9): 910-913
Grygalewicz, J.; Niznikowska-Marks, M.J.; Kozierowska, T.; Ogińska, Z.; Rzacka, D. 1981: Subcutaneous administration of heparin in children. I. Heparin in small "pediatric" doses Pediatria Polska 56(7): 783-787
Oberst, M.; Vierling, P.; Thielemann, F. 1998: Heparin-associated thrombocytopenia (HAT) type II. An underestimated complication in prevention of thromboembolism with heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 69(2): 198-203